129 related articles for article (PubMed ID: 23711069)
1. miR-155 is involved in tumor progression of mycosis fungoides.
Moyal L; Barzilai A; Gorovitz B; Hirshberg A; Amariglio N; Jacob-Hirsch J; Maron L; Feinmesser M; Hodak E
Exp Dermatol; 2013 Jun; 22(6):431-3. PubMed ID: 23711069
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides.
Benner MF; Ballabio E; van Kester MS; Saunders NJ; Vermeer MH; Willemze R; Lawrie CH; Tensen CP
Exp Dermatol; 2012 Aug; 21(8):632-4. PubMed ID: 22776000
[TBL] [Abstract][Full Text] [Related]
3. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
4. CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation.
Hu SC; Lin CL; Hong CH; Yu HS; Chen GS; Lee CH
J Dermatol Sci; 2014 Apr; 74(1):31-8. PubMed ID: 24411580
[TBL] [Abstract][Full Text] [Related]
5. Altered microRNA expression in mycosis fungoides.
Maj J; Jankowska-Konsur A; Sadakierska-Chudy A; Noga L; Reich A
Br J Dermatol; 2012 Feb; 166(2):331-6. PubMed ID: 21966986
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
7. Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides.
Daggett RN; Kurata M; Abe S; Onishi I; Miura K; Sawada Y; Tanizawa T; Kitagawa M
Br J Dermatol; 2014 Oct; 171(4):722-31. PubMed ID: 24725174
[TBL] [Abstract][Full Text] [Related]
8. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
[TBL] [Abstract][Full Text] [Related]
9. T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides.
Thurber SE; Zhang B; Kim YH; Schrijver I; Zehnder J; Kohler S
J Am Acad Dermatol; 2007 Nov; 57(5):782-90. PubMed ID: 17646032
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD31 in Mycosis Fungoides.
Jankowska-Konsur A; Kobierzycki C; Grzegrzolka J; Piotrowska A; Gomulkiewicz A; Glatzel-Plucinska N; Olbromski M; Podhorska-Okolow M; Szepietowski JC; Dziegiel P
Anticancer Res; 2016 Sep; 36(9):4575-82. PubMed ID: 27630298
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic-molecular correlation in early mycosis fungoides using T-cell receptor gamma gene rearrangement by polymerase chain reaction with laser capture microdissection.
Hsiao PF; Hsiao CH; Lin YC; Tseng MP; Tsai TF; Jee SH
J Formos Med Assoc; 2007 Apr; 106(4):265-72. PubMed ID: 17475602
[TBL] [Abstract][Full Text] [Related]
12. Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients.
Talaat IM; Abdelmaksoud RE; Guimei M; Agamia NF; Nugud A; El-Serafi AT
PLoS One; 2019; 14(10):e0224305. PubMed ID: 31648231
[TBL] [Abstract][Full Text] [Related]
13. Monoclonality of intraepidermal T lymphocytes in early mycosis fungoides detected by molecular analysis after laser-beam-based microdissection.
Cerroni L; Arzberger E; Ardigò M; Pütz B; Kerl H
J Invest Dermatol; 2000 Jun; 114(6):1154-7. PubMed ID: 10844559
[TBL] [Abstract][Full Text] [Related]
14. The expression of CXCR3 and CD30 in mycosis fungoides.
Nikoo A
Arch Iran Med; 2012 Mar; 15(3):146-50. PubMed ID: 22369302
[TBL] [Abstract][Full Text] [Related]
15. miRNA expression profiling of mycosis fungoides.
van Kester MS; Ballabio E; Benner MF; Chen XH; Saunders NJ; van der Fits L; van Doorn R; Vermeer MH; Willemze R; Tensen CP; Lawrie CH
Mol Oncol; 2011 Jun; 5(3):273-80. PubMed ID: 21406335
[TBL] [Abstract][Full Text] [Related]
16. Comparative morphometric analysis of intraepidermal and dermal lymphocytes in early mycosis fungoides and some inflammatory dermatoses.
Gamsizkan M; Demiriz M; Karslioğlu Y; Günhan O
Anal Quant Cytol Histol; 2007 Jun; 29(3):153-8. PubMed ID: 17672375
[TBL] [Abstract][Full Text] [Related]
17. Clonal T cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in the skin and blood of patients with parapsoriasis and early-stage mycosis fungoides.
Klemke CD; Dippel E; Dembinski A; Pönitz N; Assaf C; Hummel M; Stein H; Goerdt S
J Pathol; 2002 Jul; 197(3):348-54. PubMed ID: 12115881
[TBL] [Abstract][Full Text] [Related]
18. Expression of human beta-defensins in patients with mycosis fungoides.
Gambichler T; Skrygan M; Appelhans C; Tomi NS; Reinacher-Schick A; Altmeyer P; Kreuter A
Arch Dermatol Res; 2007 Jul; 299(4):221-4. PubMed ID: 17415576
[TBL] [Abstract][Full Text] [Related]
19. Unilesional mycosis fungoides is associated with increased expression of microRNA-17~92 and T helper 1 skewing.
Moyal L; Gorovitz-Haris B; Yehezkel S; Jacob-Hirsch J; Bershtein V; Barzilai A; Rotem C; Sherman S; Amitay-Laish I; Feinmesser M; Hodak E
Br J Dermatol; 2019 May; 180(5):1123-1134. PubMed ID: 30431147
[TBL] [Abstract][Full Text] [Related]
20. Expression of T-cell receptor-γδ in normal human skin, inflammatory dermatoses and mycosis fungoides.
Hocker TL; Wada DA; El-Azhary R; Gibson LE
J Cutan Pathol; 2012 Apr; 39(4):419-24. PubMed ID: 22390212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
